Sharkis SJ - Search Results

1

Growth factor-mediated terminal differentiation of chronic myeloid leukemia.

Bedi A, Griffin CA, Barber JP, Vala MS, Hawkins AL, Sharkis SJ, Zehnbauer BA, Jones RJ. Bedi A, et al. Among authors: sharkis sj. Cancer Res. 1994 Nov 1;54(21):5535-8. Cancer Res. 1994. PMID: 7923192

2

Characterization of chronic myeloid leukemia stem cells.

Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W, Gocke CD, Sharkis SJ, Levitsky HI, Jones RJ. Gerber JM, et al. Among authors: sharkis sj. Am J Hematol. 2011 Jan;86(1):31-7. doi: 10.1002/ajh.21915. Am J Hematol. 2011. PMID: 21132730 Free PMC article.

3

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia.

Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Bedi A, et al. Among authors: sharkis sj. Blood. 1994 Apr 15;83(8):2038-44. Blood. 1994. PMID: 8161775 Free article.

4

BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia.

Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ. Bedi A, et al. Among authors: sharkis sj. Blood. 1993 Jun 1;81(11):2898-902. Blood. 1993. PMID: 8499629 Free article.

5

The estrogen receptor CpG island is methylated in most hematopoietic neoplasms.

Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, Kaufmann SH, Baylin SB. Issa JP, et al. Among authors: sharkis sj. Cancer Res. 1996 Mar 1;56(5):973-77. Cancer Res. 1996. PMID: 8640788

6

Mechanisms of cell commitment in myeloid cell differentiation.

Bedi A, Sharkis SJ. Bedi A, et al. Among authors: sharkis sj. Curr Opin Hematol. 1995 Jan;2(1):12-21. doi: 10.1097/00062752-199502010-00003. Curr Opin Hematol. 1995. PMID: 9371967 Review.

7

A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

Gerber JM, Smith BD, Ngwang B, Zhang H, Vala MS, Morsberger L, Galkin S, Collector MI, Perkins B, Levis MJ, Griffin CA, Sharkis SJ, Borowitz MJ, Karp JE, Jones RJ. Gerber JM, et al. Among authors: sharkis sj. Blood. 2012 Apr 12;119(15):3571-7. doi: 10.1182/blood-2011-06-364182. Epub 2012 Jan 19. Blood. 2012. PMID: 22262762 Free PMC article.

8

Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity.

Jones RJ, Collector MI, Barber JP, Vala MS, Fackler MJ, May WS, Griffin CA, Hawkins AL, Zehnbauer BA, Hilton J, Colvin OM, Sharkis SJ. Jones RJ, et al. Among authors: sharkis sj. Blood. 1996 Jul 15;88(2):487-91. Blood. 1996. PMID: 8695796 Free article.

9

Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase.

Yao SL, Akhtar AJ, McKenna KA, Bedi GC, Sidransky D, Mabry M, Ravi R, Collector MI, Jones RJ, Sharkis SJ, Fuchs EJ, Bedi A. Yao SL, et al. Among authors: sharkis sj. Nat Med. 1996 Oct;2(10):1140-3. doi: 10.1038/nm1096-1140. Nat Med. 1996. PMID: 8837615

10

Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1beta-converting enzyme-related proteases.

Yao SL, McKenna KA, Sharkis SJ, Bedi A. Yao SL, et al. Among authors: sharkis sj. Cancer Res. 1996 Oct 15;56(20):4551-5. Cancer Res. 1996. PMID: 8840958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters